Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (581-590 of 715) with videos related to

Pageof 72
Sort By:
Annals of the New York Academy of Sciences|January 17, 1995
Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in miceP Carmeliet, A Bouché, C De Clercq, et al.
Thrombosis and Haemostasis|November 1, 1996
Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failureP Holvoet, J Donck, M Landeloos, et al.
The Journal of Clinical Investigation|October 28, 1998
Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in miceL R Jalbert, E D Rosen, L Moons, et al.
The Journal of Biological Chemistry|October 15, 1991
Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
The Journal of Biological Chemistry|April 5, 2000
Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acidsM Baes, S Huyghe, P Carmeliet, et al.
Thrombosis Research|April 1, 1988
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activatorH D Garabedian, H K Gold, R C Leinbach, et al.
Gene|March 14, 2001
Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elementsM Beckers, J Gabriëls, S van der Maarel, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1993
Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparationT Yasuda, H K Gold, C Kohmura, et al.
The Journal of Biological Chemistry|January 3, 1997
Identification of a multihormone responsive enhancer far upstream from the human tissue-type plasminogen activator geneF Bulens, P Merchiers, I Ibañez-Tallon, et al.
Science (New York, N.Y.)|October 9, 1987
Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activityW E Holmes, H R Lijnen, L Nelles, et al.
Pageof 72

Showing results (581-590 of 715) with videos related to

Sort By:
Pageof 72
Annals of the New York Academy of Sciences|January 17, 1995
Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator, and plasminogen activator inhibitor-1 genes in miceP Carmeliet, A Bouché, C De Clercq, et al.
Thrombosis and Haemostasis|November 1, 1996
Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failureP Holvoet, J Donck, M Landeloos, et al.
The Journal of Clinical Investigation|October 28, 1998
Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in miceL R Jalbert, E D Rosen, L Moons, et al.
The Journal of Biological Chemistry|October 15, 1991
Characterization of a chimeric plasminogen activator consisting of a single-chain Fv fragment derived from a fibrin fragment D-dimer-specific antibody and a truncated single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.
The Journal of Biological Chemistry|April 5, 2000
Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acidsM Baes, S Huyghe, P Carmeliet, et al.
Thrombosis Research|April 1, 1988
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activatorH D Garabedian, H K Gold, R C Leinbach, et al.
Gene|March 14, 2001
Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elementsM Beckers, J Gabriëls, S van der Maarel, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1993
Intravenous and endobronchial administration of G4120, a cyclic Arg-Gly-Asp-containing platelet GPIIb/IIIa receptor-blocking pentapeptide, enhances and sustains coronary arterial thrombolysis with rt-PA in a canine preparationT Yasuda, H K Gold, C Kohmura, et al.
The Journal of Biological Chemistry|January 3, 1997
Identification of a multihormone responsive enhancer far upstream from the human tissue-type plasminogen activator geneF Bulens, P Merchiers, I Ibañez-Tallon, et al.
Science (New York, N.Y.)|October 9, 1987
Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activityW E Holmes, H R Lijnen, L Nelles, et al.
Pageof 72